Structure

InChI Key LKCWBDHBTVXHDL-RMDFUYIESA-N
Smile NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O
InChI
InChI=1S/C22H43N5O13/c23-2-1-8(29)20(36)27-7-3-6(25)18(39-22-16(34)15(33)13(31)9(4-24)37-22)17(35)19(7)40-21-14(32)11(26)12(30)10(5-28)38-21/h6-19,21-22,28-35H,1-5,23-26H2,(H,27,36)/t6-,7+,8-,9+,10+,11-,12+,13+,14+,15-,16+,17-,18+,19-,21+,22+/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C22H43N5O13
Molecular Weight 585.61
AlogP -8.42
Hydrogen Bond Acceptor 17.0
Hydrogen Bond Donor 13.0
Number of Rotational Bond 10.0
Polar Surface Area 331.94
Molecular species BASE
Aromatic Rings 0.0
Heavy Atoms 40.0

Pharmacology

Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Transferase
- - - - 25

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Cystic Fibrosis 3 D003550 ClinicalTrials
Pneumonia, Bacterial 3 D018410 ClinicalTrials
Pneumonia, Ventilator-Associated 3 D053717 ClinicalTrials
Mycobacterium Infections 3 D009164 ClinicalTrials
Pneumonia 2 D011014 ClinicalTrials
Tuberculosis 1 D014376 ClinicalTrials
Pulmonary Disease, Chronic Obstructive 0 D029424 ClinicalTrials
Osteomyelitis 0 D010019 ClinicalTrials

Related Entries

MCS

Scaffolds

Salt

Cross References

Resources Reference
CAS NUMBER 37517-28-5
ChEBI 2637
ChEMBL CHEMBL177
DrugBank DB00479
DrugCentral 157
EPA CompTox DTXSID3022586
FDA SRS 84319SGC3C
Human Metabolome Database HMDB0014622
Guide to Pharmacology 10894
KEGG C06820
PDB AKN
PharmGKB PA164744372
PubChem 37768
SureChEMBL SCHEMBL2985
ZINC ZINC000008214483